Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Ayala Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2023 | Q4 2022 | N/A | -$0.62 | N/A | N/A | $105.00 K |
| 11/03/2022 | Q3 2022 | -$0.49 | -$0.66 | -0.17 | N/A | $91.00 K |
| 08/15/2022 | Q2 2022 | -$0.65 | -$0.54 | 0.11 | N/A | $38.00 K |
| 05/16/2022 | Q1 2022 | N/A | -$0.66 | N/A | N/A | $458.00 K |
| 03/28/2022 | Q4 2021 | -$0.61 | -$0.59 | 0.02 | N/A | $-2,360,000 |
| 11/15/2021 | Q3 2021 | -$0.80 | -$0.68 | 0.12 | N/A | $625.00 K |
| 08/12/2021 | Q2 2021 | -$0.63 | -$0.75 | -0.12 | N/A | $761.00 K |
| 05/14/2021 | Q1 2021 | -$0.71 | -$0.74 | -0.03 | N/A | $974.00 K |
| 03/24/2021 | Q4 2020 | N/A | -$0.73 | N/A | N/A | $1.00 M |
| 11/16/2020 | Q3 2020 | -$0.55 | -$0.59 | -0.04 | N/A | $658.00 K |
| 08/12/2020 | Q2 2020 | N/A | -$0.74 | N/A | N/A | $1.05 M |
| 06/22/2020 | Q1 2020 | N/A | -$0.54 | N/A | N/A | $1.00 M |
| 12/30/2019 | Q4 2019 | N/A | -$0.45 | N/A | N/A | $372.00 K |
| 09/29/2019 | Q3 2019 | N/A | -$0.59 | N/A | N/A | $845.00 K |
| 06/29/2019 | Q2 2019 | N/A | -$0.44 | N/A | N/A | $852.00 K |
| 03/30/2019 | Q1 2019 | N/A | -$0.41 | N/A | N/A | $265.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ayala Pharmaceuticals, Inc. Earnings: FAQ's
Ayala Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 27th, 2023 based offlast year's report dates.
The conference call for Ayala Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Ayala Pharmaceuticals, Inc.'s latest earnings report can be read online.
Ayala Pharmaceuticals, Inc. (:AYLA) has a recorded annual revenue of $692.00 K.
Ayala Pharmaceuticals, Inc. (:AYLA) has a recorded net income of $-38,013,000.Ayala Pharmaceuticals, Inc. has generated $-2.46 earnings per share over the last four quarters.
Ayala Pharmaceuticals, Inc. (:AYLA) has a price-to-earnings ratio of -0.22 and price/earnings-to-growth ratio is -0.